Rasmussen had ‘non-negative’ at Tour
The head of France’s Anti-Doping Agency said Friday that Danish rider Michael Rasmussen submitted a sample that showed signs of the presence of Erythropoietin at this year’s Tour de France. AFLD President Pierre Bordry cautioned, however, that the sample does not qualify as a positive, because the substance in question is a new version of the drug EPO that is much closer to human erythropoietin than the established version of the drug, Epogen. "Traces of Dynepo, a biosimilar EPO, were found in Rasmussen's urine," AFLD President Pierre Bordry told the Reuters news service on Friday.